COGNIGENICS

At Cognigenics, we are pioneering new approaches to treating mental health disorders and neurocognitive disorders. Our cutting-edge, patent-pending technology employs genetic neuroengineering techniques to accurately and noninvasively target the neural networks implicated in conditions such as anxiety, depression, cognitive decline and memory... Leveraging the precise application of short hairpin RNA (shRNA)-based therapeutics, our technology mitigates the harmful consequences of chronic stress and disorders arising from chronic neural dysregulation, including (but not limited to) Anxiety Spectrum Disorders (ASD), Mild Cognitive Impairment (MCI), and Alzheimer's Disease (AD)... Pioneering the frontier of RNA-based therapeutics for mental health. Transforming Mental Health in the Genetic Age Cognigenics is at the forefront of advancing RNA-based therapeutics, revolutionizing treatment for mental health disorders.At Cognigenics, we are pioneering new approaches to treating mental..

Also known as: Cognigenics, Inc.

Primary location: Stuart United States